BioMendics, LLC: Clinical Trials

4 trials sponsored by BioMendics, LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 1, Recruiting 1

Follow BioMendics, LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
5% TolaSure Topical Gel, Topical Placebo Gel - Epidermolysis Bullosa Simplex
Phase 2RecruitingBioMendics, LLC402025-09-112026-08-13
Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex
TolaSure Topical Gel, Vehicle Topical Gel - Epidermolysis Bullosa Simplex
Phase 1CompletedBioMendics, LLC62022-05-052023-09-11
Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants
TolaSure Topical Gel, Topical Vehicle Gel - Wound Healing
Phase 2CompletedBioMendics, LLC722019-08-262021-06-24
Safety and Efficacy of Topical TolaSure on Skin Punch Biopsies in Healthy Participants
TolaSure Topical Gel - Wound Healing
Phase 1CompletedBioMendics, LLC222018-07-162019-01-30

Conditions studied

Epidermolysis Bullosa (2)  ·  Epidermolysis Bullosa Simplex (2)  ·  Skin Abnormalities (2)  ·  Skin Diseases (2)

Countries

United States (4)

Top investigators

Karen McGuire, PhD (1)